Fundamental CF research has set the stage for a better molecular understanding of CFTR mutations by supplying structural pieces of information to design new approaches for the pharmacology dynamic even if the different drugs proposed were obtained by high-throughput screening (Callebaut et al., 2017). The gene discussed is CFTR; the disease is cystic fibrosis.